ACCESSION: MSBNK-SMB_Measured-HSA032P0215001
RECORD_TITLE: Characterized; Valyl-Proline; LC-ESI-QTOF; MS2; POSITIVE; generated fron DDA dataset
DATE: 2025.04.02 (Averaged 2025.02.25, Processed 2025.02.25, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Yu et al. Front Cell Infect Microbiol. 2022,11,763507
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was characterized at Level 3 automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS3233
COMMENT: DATASET_TITLE The gut microbiome and metabolites are altered and interrelated in patients with rheumatoid arthritis
COMMENT: DATASET_AUTHORS Die Yu, Juping Du, Xia Pu, Liyuan Zheng, Shuaishuai Chen, Na Wang, Jun Li, Shiyong Chen, Shaobiao Pan, Bo Shen
COMMENT: MS1_M/Z_AVERAGED_THRES 15.000
COMMENT: MS2_M/Z_AVERAGED_THRES 20.000
COMMENT: DATASET_FILE_NUM 60
COMMENT: NUM_AVERAGED_SPEC 27
COMMENT: RAW_SPEC {'RA1-pos_1645': {'bp': 12445.0, 'sum': 42737.0}, 'HC12-pos_1551': {'bp': 6740.0, 'sum': 20727.0}, 'HC15-pos_1533': {'bp': 6303.0, 'sum': 19757.0}, 'HC17-pos_1381': {'bp': 5648.0, 'sum': 18005.0}, 'RA26-pos_1392': {'bp': 5083.0, 'sum': 17893.0}, 'RA21-pos_1178': {'bp': 4327.0, 'sum': 13528.0}, 'RA20-pos_1525': {'bp': 4194.0, 'sum': 16731.0}, 'RA8-pos_1424': {'bp': 3964.0, 'sum': 14166.0}, 'HC25-pos_1463': {'bp': 3756.0, 'sum': 12376.0}, 'RA24-pos_1286': {'bp': 3676.0, 'sum': 12782.0}, 'RA2-pos_1586': {'bp': 3547.0, 'sum': 15963.0}, 'HC10-pos_1466': {'bp': 3470.0, 'sum': 14025.0}, 'RA25-pos_1406': {'bp': 3466.0, 'sum': 10460.0}, 'RA3-pos_1450': {'bp': 3290.0, 'sum': 12111.0}, 'RA4-pos_1432': {'bp': 3023.0, 'sum': 10549.0}, 'RA13-pos_1401': {'bp': 2665.0, 'sum': 8476.0}, 'RA23-pos_1401': {'bp': 2352.0, 'sum': 7211.0}, 'QC3-pos_1401': {'bp': 2103.0, 'sum': 6564.0}, 'RA18-pos_1452': {'bp': 1968.0, 'sum': 9323.0}, 'RA6-pos_1340': {'bp': 1887.0, 'sum': 7384.0}, 'QC5-pos_1376': {'bp': 1801.0, 'sum': 5614.0}, 'QC8-pos_1344': {'bp': 1648.0, 'sum': 5961.0}, 'HC9-pos_1355': {'bp': 1445.0, 'sum': 4475.0}, 'QC7-pos_1350': {'bp': 1358.0, 'sum': 3210.0}, 'QC4-pos_1424': {'bp': 1159.0, 'sum': 4626.0}, 'RA12-pos_1593': {'bp': 1026.0, 'sum': 3623.0}, 'RA22-pos_1264': {'bp': 911.0, 'sum': 3907.0}}
COMMENT: RETENTION_TIME_STDEV 0.006
COMMENT: PRECURSOR_M/Z_RAW 215.138143
COMMENT: PRECURSOR_M/Z_STDEV 0.000687
COMMENT: PRECURSOR_IN_MS1 mz 215.138704; int 943.752; delta(ppm) 9.993907
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 9.532; C8H23O4P; [M+H]+; delta(ppm) -9.531533
COMMENT: PROPOSED_MF SevenGoldenRules 1.817; C10H18N2O3; [M+H]+; delta(ppm) -1.816642
COMMENT: PROPOSED_MF MS-FINDER 4.454; C10H18N2O3; [M+H]+; delta(ppm) -1.812256
COMMENT: PROPOSED_MF MS-FINDER 2.951; C6H14N8O; [M+H]+; delta(ppm) 10.669701
COMMENT: PROPOSED_MF MS-FINDER 2.537; C6H22N4S2; [M+H]+; delta(ppm) 12.846936
COMMENT: PROPOSED_MF SIRIUS5_Sirius 29.230; C10H18N2O3; [M+H]+; delta(ppm) -1.812256
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C10H18N2O3; [M+H]+; delta(ppm) -1.812256
COMMENT: PROPOSED_MF SIRIUS6_Sirius 41.205; C10H18N2O3; [M+H]+; delta(ppm) -1.812256
COMMENT: PROPOSED_MF SIRIUS6_Sirius 31.292; C8H16N5O2; [M+H]+; delta(ppm) 4.428684
COMMENT: PROPOSED_MF SIRIUS6_Sirius 28.837; C8H17F3N2O; [M+H]+; delta(ppm) 9.553880
COMMENT: PROPOSED_MF SIRIUS6_Sirius -6.630; CH16N11S; [M+H]+; delta(ppm) 1.240952
COMMENT: PROPOSED_MF SIRIUS6_Sirius -8.193; C2H17N9OP; [M+H]+; delta(ppm) 9.232910
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C10H18N2O3; [M+H]+; delta(ppm) -1.812256
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.667; GIAZPLMMQOERPN-UHFFFAOYNA-N; [M+H]+; CC(C)C(N)C(=O)N1CCCC1C(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.025; AWJGUZSYVIVZGP-UHFFFAOYNA-N; [M+H]+; CC(C)C(NC(=O)C1CCCN1)C(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.687; SZGIMRYWFNAKJW-UHFFFAOYSA-N; [M+H]+; COCC(=O)NCCC(=O)N1CCCC1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.625; PITJAAIPVBVRAO-UHFFFAOYSA-N; [M+H]+; O=C(OC(C)(C)C)N1CCCC1C(=O)N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.297; YBXRHJWNPYZEQO-UOIDAMPHNA-N; [M+H]+; CCCC\C=C/[N+](/[O-])=N/[C@H](C)C(=O)CO
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.680; GIAZPLMMQOERPN-UHFFFAOYNA-N; [M+H]+; Valyl-Proline
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.661; AWJGUZSYVIVZGP-UHFFFAOYNA-N; [M+H]+; Prolyl-Valine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.607; AUTOLBMXDDTRRT-HGXVMFPFNA-N; [M+H]+; Dethiobiotin
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.449; PITJAAIPVBVRAO-UHFFFAOYSA-N; [M+H]+; tert-butyl 2-carbamoylpyrrolidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.369; SZGIMRYWFNAKJW-UHFFFAOYSA-N; [M+H]+; 2-methoxy-N-[3-oxo-3-(pyrrolidin-1-yl)propyl]acetamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.358; KKSIQJPREBBKBQ-UHFFFAOYSA-N; [M+H]+; 2-amino-4-(pyrrolidin-1-yl)-6,8-dioxabicyclo[3.2.1]octan-3-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.285; VJZINYIGTFCCME-UHFFFAOYSA-N; [M+H]+; 2-[(cyclopropylcarbamoyl)amino]-4-methylpentanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.147; UBJFWFZZUVUIOS-FUTZBWQWNA-N; [M+H]+; UNPD114229
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.124; CTVXMBKHEGPUCP-UHFFFAOYSA-N; [M+H]+; 4-(2-methoxyethyl)-6-methyl-octahydropyrrolo[3,4-b][1,4]oxazin-3-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.848; YBXRHJWNPYZEQO-UOIDAMPHNA-N; [M+H]+; UNPD66072
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.574; DYJKDQDOWWFHKQ-SREVYHEPSA-N; [M+H]+; UNPD217811
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.318; SXIILERIAIKHJG-UHFFFAOYSA-N; [M+H]+; tert-butyl N-[2-(prop-2-enoylamino)ethyl]carbamate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.285; SNBONYSNCLHAOU-UWVGGRQHSA-N; [M+H]+; Monascustin
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; SZGIMRYWFNAKJW-UHFFFAOYSA-N; [M+H]+; 2-methoxy-N-[3-oxo-3-(pyrrolidin-1-yl)propyl]acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.915; GIAZPLMMQOERPN-UHFFFAOYNA-N; [M+H]+; Valyl-Proline
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.865; AWJGUZSYVIVZGP-UHFFFAOYNA-N; [M+H]+; Prolyl-Valine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.818; AUTOLBMXDDTRRT-HGXVMFPFNA-N; [M+H]+; Dethiobiotin
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.799; KKSIQJPREBBKBQ-UHFFFAOYSA-N; [M+H]+; 2-amino-4-(pyrrolidin-1-yl)-6,8-dioxabicyclo[3.2.1]octan-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.746; PITJAAIPVBVRAO-UHFFFAOYSA-N; [M+H]+; tert-butyl 2-carbamoylpyrrolidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.681; CTVXMBKHEGPUCP-UHFFFAOYSA-N; [M+H]+; 4-(2-methoxyethyl)-6-methyl-octahydropyrrolo[3,4-b][1,4]oxazin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.672; VJZINYIGTFCCME-UHFFFAOYSA-N; [M+H]+; 2-[(cyclopropylcarbamoyl)amino]-4-methylpentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.651; SXIILERIAIKHJG-UHFFFAOYSA-N; [M+H]+; tert-butyl N-[2-(prop-2-enoylamino)ethyl]carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.570; UBJFWFZZUVUIOS-FUTZBWQWNA-N; [M+H]+; UNPD114229
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.389; DYJKDQDOWWFHKQ-SREVYHEPSA-N; [M+H]+; UNPD217811
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.309; SNBONYSNCLHAOU-UWVGGRQHSA-N; [M+H]+; Monascustin
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.045; YBXRHJWNPYZEQO-UOIDAMPHNA-N; [M+H]+; UNPD66072
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.900; AUTOLBMXDDTRRT-JGVFFNPUSA-N; [M+H]+; 6-[(4R,5S)-5-methyl-2-oxoimidazolidin-4-yl]hexanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.683; AWJGUZSYVIVZGP-UHFFFAOYSA-N; [M+H]+; 3-methyl-2-(pyrrolidine-2-carbonylamino)butanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.333; ZMTYSXSSJRPNJH-UHFFFAOYSA-N; [M+H]+; 2-(dimethylamino)ethyl 2-(2-oxopyrrolidin-1-yl)acetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.276; CJTWMOJBXOUGAM-UHFFFAOYSA-N; [M+H]+; tert-butyl N-(1-isocyanato-2-methylpropan-2-yl)carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.254; SSBSATYPIISWFD-ZETCQYMHSA-N; [M+H]+; tert-butyl N-[(3S)-2-oxopiperidin-3-yl]carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.244; IIYJKESUJITBBK-UHFFFAOYSA-N; [M+H]+; tert-butyl N-[(5-oxopyrrolidin-3-yl)methyl]carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.242; FQYPKQOQUNFBDP-QMMMGPOBSA-N; [M+H]+; (2S)-6-amino-2-(2-methylprop-2-enoylamino)hexanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.241; PZWABQHORAPCEB-VIFPVBQESA-N; [M+H]+; N-[3-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-3-oxopropyl]acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.228; CDWJRRPTGQQFDP-UHFFFAOYSA-N; [M+H]+; tert-butyl N-(2-oxopiperidin-4-yl)carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.227; KBNSUMIBERIFIT-UHFFFAOYSA-N; [M+H]+; tert-butyl N-(6-oxopiperidin-3-yl)carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.222; BZUBYWOANCHCFS-UHFFFAOYSA-N; [M+H]+; tert-butyl N-(3-methyl-5-oxopyrrolidin-3-yl)carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.221; LYBRTARFAQKQLM-JTQLQIEISA-N; [M+H]+; tert-butyl N-[(3S)-3-methyl-2-oxopyrrolidin-3-yl]carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.215; PITJAAIPVBVRAO-ZETCQYMHSA-N; [M+H]+; tert-butyl (2S)-2-carbamoylpyrrolidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.167; NHDGOVOBEZPXMY-UHFFFAOYSA-N; [M+H]+; tert-butyl 3-carbamoylpyrrolidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.126; NNVNEGUYUNQMTQ-UHFFFAOYSA-N; [M+H]+; 1-(propan-2-ylcarbamoyl)piperidine-4-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.126; QGMLUXHRHAIPLM-UHFFFAOYSA-N; [M+H]+; 1-(propan-2-ylcarbamoyl)piperidine-3-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.093; GLJYPTWEXBUATJ-UHFFFAOYSA-N; [M+H]+; tert-butyl 5-oxo-1,4-diazepane-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.087; NKFAHRCLUXUXTJ-UHFFFAOYSA-N; [M+H]+; tert-butyl 4-formylpiperazine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.075; ITRUBUQWGNAYGG-UHFFFAOYSA-N; [M+H]+; tert-butyl 3-oxo-1,4-diazepane-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.075; KKVKQTLLEBWZTR-UHFFFAOYSA-N; [M+H]+; tert-butyl 2-methyl-3-oxopiperazine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.073; YHPAOPGCWGXNOO-UHFFFAOYSA-N; [M+H]+; tert-butyl N-methyl-N-(2-oxopyrrolidin-3-yl)carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.070; CSDMPDKITXDRDO-UHFFFAOYSA-N; [M+H]+; tert-butyl 3-methyl-5-oxopiperazine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.068; NYBJRGJELSODLU-ZETCQYMHSA-N; [M+H]+; tert-butyl (2S)-2-methyl-5-oxopiperazine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.062; OPHBBIXAIWSIME-UHFFFAOYSA-N; [M+H]+; ethyl 1-(2-aminoacetyl)piperidine-3-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.054; SXIILERIAIKHJG-UHFFFAOYSA-N; [M+H]+; tert-butyl N-[2-(prop-2-enoylamino)ethyl]carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.901; VATRKSAYTIKXFH-UHFFFAOYSA-N; [M+H]+; tert-butyl 6-methoxy-3,5-dihydro-2H-pyrazine-4-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.756; OKDHUMQSCWATCJ-UHFFFAOYSA-N; [M+H]+; tert-butyl 5-oxa-2,8-diazaspiro[3.4]octane-2-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.755; QHBIPTXZAICDJO-UHFFFAOYSA-N; [M+H]+; tert-butyl 3-amino-1-oxa-6-azaspiro[3.3]heptane-6-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.641; UXOROTUGAADVMK-UHFFFAOYSA-N; [M+H]+; methyl 3-(tert-butylcarbamoylamino)but-2-enoate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -0.854; GIAZPLMMQOERPN; [M+H]+; Valylproline
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -212.760; AWJGUZSYVIVZGP; [M+H]+; Prolylvaline
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -330.117; VJZINYIGTFCCME; [M+H]+; 2-(cyclopropylcarbamoylamino)-4-methylpentanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -332.268; PITJAAIPVBVRAO; [M+H]+; zlchem 118
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -370.895; IZHPCCLNIDDVFG; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -383.267; AUTOLBMXDDTRRT; [M+H]+; bmse000314
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -388.978; SZGIMRYWFNAKJW; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -400.904; SSBSATYPIISWFD; [M+H]+; t-Boc-amino-2-piperidone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -438.865; KBNSUMIBERIFIT; [M+H]+; tert-Butyl (6-oxopiperidin-3-yl)carbamate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -460.320; MUPFIGLSLOVQLZ; [M+H]+; 1-[3-(Dimethylamino)propyl]-5-oxo-3-pyrrolidinecarboxylic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -462.546; UBJFWFZZUVUIOS; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -464.073; LYBRTARFAQKQLM; [M+H]+; tert-butyl N-[(3S)-3-methyl-2-oxopyrrolidin-3-yl]carbamate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -477.231; UXOROTUGAADVMK; [M+H]+; methyl (Z)-3-(tert-butylcarbamoylamino)but-2-enoate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -477.305; GLJYPTWEXBUATJ; [M+H]+; 1-n-boc-5-oxo-1,4-diazepane
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -488.914; CTVXMBKHEGPUCP; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -490.862; RZCFMNWZMOAPRJ; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -502.413; KKSIQJPREBBKBQ; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -513.450; DYJKDQDOWWFHKQ; [M+H]+; Geralcin E
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -550.314; YBXRHJWNPYZEQO; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -556.693; QHBIPTXZAICDJO; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -575.776; SNBONYSNCLHAOU; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.992; GIAZPLMMQOERPN; [M+H]+; Valylproline
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -88.231; GIAZPLMMQOERPN; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -377.844; PITJAAIPVBVRAO; [M+H]+; tert-butyl 2-carbamoylpyrrolidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -410.445; VJZINYIGTFCCME; [M+H]+; 2-[(cyclopropylcarbamoyl)amino]-4-methylpentanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -422.182; UXOROTUGAADVMK; [M+H]+; Methyl 3-(tert-butylcarbamoylamino)but-2-enoate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -425.448; PZWABQHORAPCEB; [M+H]+; N-[3-[2-(hydroxymethyl)pyrrolidin-1-yl]-3-oxopropyl]acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -430.629; SXIILERIAIKHJG; [M+H]+; tert-butyl N-[2-(prop-2-enamido)ethyl]carbamate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -433.383; SZGIMRYWFNAKJW; [M+H]+; 2-methoxy-N-[3-oxo-3-(pyrrolidin-1-yl)propyl]acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -439.162; IIYJKESUJITBBK; [M+H]+; (R)-tert-Butyl ((5-oxopyrrolidin-3-yl)methyl)carbamate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -450.492; QGMLUXHRHAIPLM; [M+H]+; (3R)-1-(propan-2-ylcarbamoyl)piperidine-3-carboxylic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -456.968; NNVNEGUYUNQMTQ; [M+H]+; 1-[(Propan-2-yl)carbamoyl]piperidine-4-carboxylic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.998; GIAZPLMMQOERPN; [M+H]+; nan
COMMENT: CONFIDENCE Level 3: Tentative candidate, Valyl-Proline, GIAZPLMMQOERPN-UHFFFAOYNA-N; Proposed by SIRIUS6_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 CFM-ID:MsfinderDB (1), MS-FINDER:MsfinderDB (1), MetFrag:MsfinderDB (2); This structural isomer was suggested from the biological context HMDB HMDB0029135;
CH$NAME: Valyl-Proline
CH$NAME: 1-(2-amino-3-methylbutanoyl)pyrrolidine-2-carboxylic acid
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C10H18N2O3
CH$EXACT_MASS: 214.131742
CH$SMILES: CC(C)C(C(=O)N1CCCC1C(=O)O)N
CH$IUPAC: InChI=1S/C10H18N2O3/c1-6(2)8(11)9(13)12-5-3-4-7(12)10(14)15/h6-8H,3-5,11H2,1-2H3,(H,14,15)
CH$LINK: CHEBI CHEBI:73701
CH$LINK: HMDB HMDB0029135
CH$LINK: INCHIKEY GIAZPLMMQOERPN-UHFFFAOYSA-N
CH$LINK: PUBCHEM CID:5003412
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Feces
AC$INSTRUMENT: UPLC system, AB SCIEX - TripleTOF 5600+ mass spectrometer, AB SCIEX
AC$INSTRUMENT_TYPE: LC-ESI-QTOF
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 30 V
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 5.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 15.00; MS2(ppm) 20.00
AC$CHROMATOGRAPHY: COLUMN_NAME ACQUITY UPLC T3 column (1.8 Âµm, 100 mm x 2.1 mm; Waters)
AC$CHROMATOGRAPHY: FLOW_GRADIENT 0.0-0.5 min, 5% B; 0.5-7.0 min,` 100% B; 7.0-8.0 min, 100% B; 8.0-8.1 min, 5% B; 8.1-10.0 min, 5% B. 
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 2.318
MS$FOCUSED_ION: ION_TYPE [M+H]+
MS$FOCUSED_ION: PRECURSOR_M/Z 215.138629
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-00di-9200000000-7fb2f641de2cc6418942
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  55.0543131 213.3347 55.054571 17.1467 71.19 0.8879 27 f{C4H7}/1.57ppm,p-C6H12N2O3
  56.0498474 28.2673 56.050098 17.7699 17.96 0.3102 19 f{C3H6N1}/6.63ppm,p-C7H13N1O3
  57.0572811 42.9526 57.057525 16.3870 19.16 0.6900 24 f{C3H7N1}/-0.34ppm,p-C7H12N1O3
  70.0652763 892.3894 70.065426 9.0772 132.63 0.9293 27 f{C4H8N1}/2.15ppm,p-C6H11N1O3
  72.0809676 999.0000 72.081125 13.4848 59.48 0.9151 27 f{C4H10N1}/2.66ppm,p-C6H9N1O3
  84.0810680 60.9121 84.081275 18.7081 47.02 0.1464 25 f{C5H10N1}/3.48ppm,p-C5H9N1O3
  116.0710474 708.8306 116.071417 11.5447 192.56 1.0000 27 f{C5H10N1O2}/3.81ppm,p-C5H9N1O1
PK$NUM_PEAK: 7
PK$PEAK: m/z int. rel.int.
  55.054313 213.33 213
  56.049847 28.27 28
  57.057281 42.95 42
  70.065276 892.39 892
  72.080968 999.00 999
  84.081068 60.91 60
  116.071047 708.83 708
//
